Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting Report

Feasibility and initial experience in the utilization of a fully digital CZT SPECT/CT system for the diagnosis of transthyretin cardiac amyloidosis (ATTR).

Patrick Wojtylak, Norbert Avril and Arash Kardan
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3040;
Patrick Wojtylak
1Radiology/Nuclear Medicine University Hospitals of Cleveland Medical Center Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Norbert Avril
1Radiology/Nuclear Medicine University Hospitals of Cleveland Medical Center Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arash Kardan
1Radiology/Nuclear Medicine University Hospitals of Cleveland Medical Center Cleveland OH United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

3040

Introduction: Technetium-99m pyrophosphate (Tc-99m PYP) scintigraphy has been demonstrated a useful tool for the non-invasive diagnosis of transthyretin cardiac amyloidosis (ATTR). Standard planar heart to mediastinal uptake ratios (H/CL) may be confounded by blood pool activity potentially reducing the diagnostic accuracy of planar imaging. Hypothesis: Combined single-photon emission computed tomography and computed tomography (SPECT-CT) acquisition improves the performance of 99mTc PYP scintigraphy for TTR-CA. SPECT CT can reliably differentiate myocardial uptake from blood pool activity.

Methods: 27 patients with suspected ATTR had Tc-99m PYP planar and SPECT-CT scintigraphy acquired on a digital GE 670 CZT SPECT CT. The SPECT CT acquisition was 360 degree rotational scan, not a 180 degree which is standard of care (SOC), followed by a CT scan of the chest. All images were processed and reviewed by a nuclear medicine physician. The images were scored with a H/CL ratio of ≥ 1.5 at one hour classified as ATTR positive and ratios < 1.5 as ATTR negative per the ASNC guidelines. Additionally, a visual comparison of myocardial uptake relative to bone (rib) uptake was also assessed.

Results: To our knowledge, this is the first reported utilization of a fully digital CZT SPECT CT for the non-invasive diagnosis of ATTR. With this novel technique of 360 degree SPECT CT acquisition reviewers were able to better delineate the cardiac muscle from the LV cavity. Being able to fuse the SPECT and CT gives defined outlines of myocardial and the LV cavity distributions allowing for potentially better diagnosis of this underdiagnosed morbid condition.

Conclusions: Using a novel combined SPECT CT technique produces high quality images and can potentially improve in the diagnosis of ATTR compared standard planar only or planar and 180 degree SPECT techniques.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 61, Issue supplement 1
May 1, 2020
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility and initial experience in the utilization of a fully digital CZT SPECT/CT system for the diagnosis of transthyretin cardiac amyloidosis (ATTR).
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Feasibility and initial experience in the utilization of a fully digital CZT SPECT/CT system for the diagnosis of transthyretin cardiac amyloidosis (ATTR).
Patrick Wojtylak, Norbert Avril, Arash Kardan
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3040;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Feasibility and initial experience in the utilization of a fully digital CZT SPECT/CT system for the diagnosis of transthyretin cardiac amyloidosis (ATTR).
Patrick Wojtylak, Norbert Avril, Arash Kardan
Journal of Nuclear Medicine May 2020, 61 (supplement 1) 3040;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Rest Dose Spillover Correction of Stress Blood Flow Measurements in Digital Rb-82 Myocardial Perfusion PET/CT Imaging
  • Radiolabeled hyaluronic acid (HA) fragments for lymphatic imaging
  • Reduction of injected activity for MBF with a CZT Cardiac SPECT Camera
Show more

Tech Papers V: Cardiovascular Science & Neuroscience Technologist Papers

  • Flortaucipir (AV-1451) Imaging
  • 68Ga-Galmydar PET Tracer for Noninvasive Early Detection of Taxane Induced Cardiotoxicity
  • Evaluation of absolute myocardial blood flow and flow reserve using [13N]ammonia-PET/CT in comparison with 99mTc-tetrofosmin-CZT SPECT
Show more Tech Papers V: Cardiovascular Science & Neuroscience Technologist Papers

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire